BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 29997030)

  • 1. Species distribution and antifungal susceptibility among clinical isolates of Candida parapsilosis complex from India.
    Maria S; Barnwal G; Kumar A; Mohan K; Vinod V; Varghese A; Biswas R
    Rev Iberoam Micol; 2018; 35(3):147-150. PubMed ID: 29997030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Candida parapsilosis (sensu lato) isolated from hospitals located in the Southeast of Brazil: Species distribution, antifungal susceptibility and virulence attributes.
    Ziccardi M; Souza LO; Gandra RM; Galdino AC; Baptista AR; Nunes AP; Ribeiro MA; Branquinha MH; Santos AL
    Int J Med Microbiol; 2015 Dec; 305(8):848-59. PubMed ID: 26319940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Species distribution, virulence factors, and antifungal susceptibility among Candida parapsilosis complex isolates from clinical specimens at Siriraj Hospital, Thailand, from 2011 to 2015.
    Pharkjaksu S; Chongtrakool P; Suwannakarn K; Ngamskulrungroj P
    Med Mycol; 2018 Jun; 56(4):426-433. PubMed ID: 28992058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular epidemiology and antifungal susceptibility of Candida parapsilosis sensu stricto, Candida orthopsilosis, and Candida metapsilosis in Taiwan.
    Chen YC; Lin YH; Chen KW; Lii J; Teng HJ; Li SY
    Diagn Microbiol Infect Dis; 2010 Nov; 68(3):284-92. PubMed ID: 20851551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and antifungal susceptibility patterns of new cryptic species inside the species complexes Candida parapsilosis and Candida glabrata among blood isolates from a Spanish tertiary hospital.
    Miranda-Zapico I; Eraso E; Hernández-Almaraz JL; López-Soria LM; Carrillo-Muñoz AJ; Hernández-Molina JM; Quindós G
    J Antimicrob Chemother; 2011 Oct; 66(10):2315-22. PubMed ID: 21795259
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Zhang W; Zhan M; Wang N; Fan J; Han X; Li C; Liu J; Li J; Hou Y; Wang X; Zhang Z
    J Med Microbiol; 2023 Mar; 72(3):. PubMed ID: 36920840
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevalence, distribution, and antifungal susceptibility profiles of Candida parapsilosis, C. orthopsilosis, and C. metapsilosis in a tertiary care hospital.
    Silva AP; Miranda IM; Lisboa C; Pina-Vaz C; Rodrigues AG
    J Clin Microbiol; 2009 Aug; 47(8):2392-7. PubMed ID: 19494078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antifungal susceptibility and virulence of Candida parapsilosis species complex: an overview of their pathogenic potential.
    Brilhante RSN; Sales JA; da Silva MLQ; de Oliveira JS; Pereira LA; Pereira-Neto WA; Cordeiro RA; Sidrim JJC; Castelo-Branco DSCM; Rocha MFG
    J Med Microbiol; 2018 Jul; 67(7):903-914. PubMed ID: 29846153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution, virulence attributes and antifungal susceptibility patterns of Candida parapsilosis complex strains isolated from clinical samples.
    Tosun I; Akyuz Z; Guler NC; Gulmez D; Bayramoglu G; Kaklikkaya N; Arikan-Akdagli S; Aydin F
    Med Mycol; 2013 Jul; 51(5):483-92. PubMed ID: 23216051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and antifungal susceptibility profiles of Candida glabrata, Candida parapsilosis and their close-related species in oral candidiasis.
    Miranda-Cadena K; Marcos-Arias C; Mateo E; Aguirre JM; Quindós G; Eraso E
    Arch Oral Biol; 2018 Nov; 95():100-107. PubMed ID: 30096698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular identification and antifungal susceptibility profiles of Candida parapsilosis complex species isolated from culture collection of clinical samples.
    Ataides FS; Costa CR; Souza LK; Fernandes Od; Jesuino RS; Silva Mdo R
    Rev Soc Bras Med Trop; 2015; 48(4):454-9. PubMed ID: 26312937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative in vitro activities of seven antifungal drugs against clinical isolates of Candida parapsilosis complex.
    Khodavaisy S; Badali H; Meis JF; Modiri M; Mahmoudi S; Abtahi H; Salehi M; Dehghan Manshadi SA; Aala F; Agha Kuchak Afshari S; Lotfali E; Ahangarkani F; Rezaie S
    J Mycol Med; 2020 Sep; 30(3):100968. PubMed ID: 32386800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency, virulence factors and antifungal susceptibility of Candida parapsilosis species complex isolated from patients with candidemia in the central region of Argentina.
    Vigezzi C; Icely PA; Dudiuk C; Rodríguez E; Miró MS; Castillo GDV; Azcurra AI; Abiega C; Caeiro JP; Riera FO; García-Effrón G; Sotomayor CE
    J Mycol Med; 2019 Dec; 29(4):285-291. PubMed ID: 31668524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and antifungal susceptibility of Candida parapsilosis complex isolates collected from oral cavities of HIV-infected individuals.
    Moris DV; Melhem MSC; Martins MA; Souza LR; Kacew S; Szeszs MW; Carvalho LR; Pimenta-Rodrigues MV; Berghs HAM; Mendes RP
    J Med Microbiol; 2012 Dec; 61(Pt 12):1758-1765. PubMed ID: 22956748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virulence factors, antifungal susceptibility and molecular mechanisms of azole resistance among Candida parapsilosis complex isolates recovered from clinical specimens.
    Neji S; Hadrich I; Trabelsi H; Abbes S; Cheikhrouhou F; Sellami H; Makni F; Ayadi A
    J Biomed Sci; 2017 Sep; 24(1):67. PubMed ID: 28870262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Identification, Genotypic Diversity, Antifungal Susceptibility, and Clinical Outcomes of Infections Caused by Clinically Underrated Yeasts,
    Arastehfar A; Khodavaisy S; Daneshnia F; Najafzadeh MJ; Mahmoudi S; Charsizadeh A; Salehi MR; Zarrinfar H; Raeisabadi A; Dolatabadi S; Zare Shahrabadi Z; Zomorodian K; Pan W; Hagen F; Boekhout T
    Front Cell Infect Microbiol; 2019; 9():264. PubMed ID: 31417877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence, distribution and antifungal susceptibility profiles of Candida parapsilosis, Candida orthopsilosis and Candida metapsilosis bloodstream isolates.
    Bonfietti LX; Martins MDA; Szeszs MW; Pukiskas SBS; Purisco SU; Pimentel FC; Pereira GH; Silva DC; Oliveira L; Melhem MSC
    J Med Microbiol; 2012 Jul; 61(Pt 7):1003-1008. PubMed ID: 22493277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Molecular identification and in vitro antifungal susceptibility of blood isolates of the Candida parapsilosis species complex in Venezuela].
    Moreno X; Reviakina V; Panizo MM; Ferrara G; García N; Alarcón V; Garcés MF; Dolande M
    Rev Iberoam Micol; 2017; 34(3):165-170. PubMed ID: 28457646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Candida orthopsilosis fungemias in a Spanish tertiary care hospital: incidence, epidemiology and antifungal susceptibility.
    Blanco-Blanco MT; Gómez-García AC; Hurtado C; Galán-Ladero MA; Lozano Mdel C; García-Tapias A; Blanco MT
    Rev Iberoam Micol; 2014; 31(2):145-8. PubMed ID: 23680638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic Diversity and Antifungal Susceptibility of Candida parapsilosis Sensu Stricto Isolated from Bloodstream Infections in Turkish Patients.
    Hilmioğlu-Polat S; Sharifynia S; Öz Y; Aslan M; Gündoğdu N; Serin A; Rafati H; Mohammadi F; Yeşim-Metin D; Döğen A; Ilkit M; Seyedmousavi S
    Mycopathologia; 2018 Aug; 183(4):701-708. PubMed ID: 29725811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.